SALVARANI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 76.364
AS - Asia 36.162
EU - Europa 33.681
SA - Sud America 5.873
AF - Africa 815
OC - Oceania 206
Continente sconosciuto - Info sul continente non disponibili 56
Totale 153.157
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 74.946
SG - Singapore 11.539
GB - Regno Unito 10.297
CN - Cina 8.984
IT - Italia 5.907
HK - Hong Kong 5.204
BR - Brasile 4.563
SE - Svezia 4.299
VN - Vietnam 4.184
FI - Finlandia 3.162
DE - Germania 2.477
UA - Ucraina 1.598
FR - Francia 1.443
RU - Federazione Russa 1.413
TR - Turchia 1.289
KR - Corea 984
BG - Bulgaria 787
IN - India 674
ID - Indonesia 617
CA - Canada 574
JP - Giappone 553
NL - Olanda 484
AR - Argentina 447
BD - Bangladesh 414
MX - Messico 395
IE - Irlanda 329
IQ - Iraq 326
PK - Pakistan 231
ES - Italia 230
BZ - Belize 227
ZA - Sudafrica 203
EC - Ecuador 198
PL - Polonia 197
AT - Austria 195
AU - Australia 173
AE - Emirati Arabi Uniti 168
CO - Colombia 155
CL - Cile 138
EG - Egitto 120
MA - Marocco 119
VE - Venezuela 113
LT - Lituania 110
CH - Svizzera 108
TN - Tunisia 107
PH - Filippine 105
MY - Malesia 98
SA - Arabia Saudita 90
BE - Belgio 89
PE - Perù 87
CZ - Repubblica Ceca 82
HU - Ungheria 79
UZ - Uzbekistan 79
PY - Paraguay 73
KE - Kenya 70
TH - Thailandia 67
JO - Giordania 66
DZ - Algeria 65
TW - Taiwan 57
IR - Iran 53
NP - Nepal 52
DK - Danimarca 50
AZ - Azerbaigian 47
PT - Portogallo 47
UY - Uruguay 47
BO - Bolivia 42
DO - Repubblica Dominicana 42
RO - Romania 42
EU - Europa 38
AL - Albania 37
IL - Israele 37
GR - Grecia 33
RS - Serbia 33
CR - Costa Rica 31
NZ - Nuova Zelanda 28
OM - Oman 26
JM - Giamaica 25
SN - Senegal 25
BY - Bielorussia 24
KZ - Kazakistan 23
BH - Bahrain 22
ET - Etiopia 22
EE - Estonia 21
LB - Libano 21
KG - Kirghizistan 20
HN - Honduras 19
KW - Kuwait 19
PA - Panama 18
GT - Guatemala 17
LV - Lettonia 17
SY - Repubblica araba siriana 17
NO - Norvegia 16
PS - Palestinian Territory 16
HR - Croazia 14
SK - Slovacchia (Repubblica Slovacca) 14
KH - Cambogia 12
MD - Moldavia 12
NG - Nigeria 12
NI - Nicaragua 12
SV - El Salvador 12
TT - Trinidad e Tobago 12
Totale 152.915
Salva come PNG Salva come JPEG
Città #
Fairfield 8.612
Singapore 7.169
Southend 6.696
Santa Clara 6.654
Ashburn 6.512
Woodbridge 5.937
Hong Kong 5.130
Houston 4.090
Chandler 3.411
Seattle 3.183
Wilmington 2.845
Jacksonville 2.769
Cambridge 2.631
Hefei 2.593
Helsinki 2.558
San Jose 2.535
Ann Arbor 2.339
London 2.235
Dearborn 1.912
Stockholm 1.818
Beijing 1.810
The Dalles 1.400
Modena 1.382
Ho Chi Minh City 1.328
Nyköping 1.168
Council Bluffs 1.046
San Diego 996
Hanoi 976
Seoul 907
Los Angeles 905
New York 808
Princeton 778
Chicago 764
Sofia 751
Lauterbourg 711
Dallas 649
Buffalo 588
Eugene 560
Moscow 550
Milan 501
Jakarta 449
Izmir 427
Munich 389
São Paulo 384
Shanghai 356
Dublin 292
Tokyo 275
Salt Lake City 264
Bologna 245
Frankfurt am Main 241
Belize City 227
Rome 218
Columbus 203
Redwood City 199
Orem 191
Da Nang 190
Las Vegas 177
Toronto 175
Haiphong 168
Rio de Janeiro 159
Atlanta 155
Boardman 149
Nuremberg 148
Redondo Beach 138
Kent 124
Mexico City 122
Guangzhou 115
Warsaw 113
Baghdad 112
Porto Alegre 109
Norwalk 108
Amsterdam 107
Brooklyn 107
Falls Church 105
Elk Grove Village 103
Tampa 99
Parma 98
Brasília 97
Bremen 97
Johannesburg 97
Reggio Emilia 96
Saint Louis 96
Nanjing 95
Belo Horizonte 92
San Francisco 90
Boston 88
Falkenstein 86
Lappeenranta 86
Montreal 86
Biên Hòa 83
Chennai 82
Denver 81
Ankara 80
Kilburn 80
Reggio Nell'emilia 79
Mumbai 78
Kunming 76
Manchester 76
Paris 76
Phoenix 76
Totale 109.421
Salva come PNG Salva come JPEG
Nome #
64 Cu and fluorescein labeled anti-miRNA peptide nucleic acids for the detection of miRNA expression in living cells 1.994
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.332
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 505
Anti-TNF-α drugs differently affect the TNFa-sTNFR system and monocyte subsets in patients with psoriasis 455
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 448
Prevalence of SARS-CoV-2 (Covid-19) in Italians and in immigrants in an area of Northern Italy (Reggio Emilia) 430
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 398
The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria 355
Adult Primary Central Nervous System Vasculitis 353
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 353
Validation of the classification criteria for cryoglobulinaemic vasculitis 352
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 343
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 339
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy 326
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 326
Visual loss and other cranial ischaemic complications in giant cell arteritis 325
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 321
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 320
Rituximab therapy for Takayasu arteritis: A seven patients experience and a review of the literature 316
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine 314
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 311
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease 310
Retroperitoneal fibrosis 307
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 304
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 303
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility 302
Comment on: Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis: Reply 302
Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? 299
Clinical features of polymyalgia rheumatica and giant cell arteritis 298
Role of PD-L1 in licensing immunoregulatory function of dental pulp mesenchymal stem cells 297
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 296
Epidemiology of psoriatic arthritis 294
Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome 292
Ultrasound Examination of Common Carotid Adventitial Thickness Can Differentiate Takayasu Arteritis and Large Vessel Giant Cell Arteritis 291
A comprehensive review on the role of mesenchymal stromal/stem cells in the management of rheumatoid arthritis 291
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 290
(18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis 290
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 286
Acute exacerbation of interstitial lung disease associated with rheumatic disease 286
Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation: A Single-Institution 25-Year Experience 283
Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study 280
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice 280
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 280
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 279
2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative 278
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease 278
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 278
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 277
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 277
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 275
Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations 275
Biotherapies in large vessel vasculitis 274
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 274
Polymyalgia rheumatica 274
Anti-drug antibody detection with label-free electrolyte-gated organic field-effect transistors 274
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 273
Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients 273
Imaging of vasculitis: State of the art 272
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 272
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 272
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 272
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 271
Comment on: Rituximab therapy for takayasu arteritis: A seven patients experience and a review of the literature: Reply 267
Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica 267
EULAR guidelines on ANCA-associated vasculitis in the real life 267
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 266
Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy 263
Recent advances in the diagnosis and treatment of polymyalgia rheumatica 263
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 261
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature 259
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 259
Unmet Needs in the Pathogenesis and Treatment of Vasculitides 259
Biologics in vasculitides: Where do we stand, where do we go from now? 258
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 258
The role of infectious agents in the pathogenesis of vasculitis 257
2018 Update of the EULAR recommendations for the management of large vessel vasculitis 257
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 257
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 256
Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study 256
Polymyalgia rheumatica and giant-cell arteritis 255
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 254
[18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis 253
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 253
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 253
Takayasu's arteritis: A study of 104 Italian patients 252
Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease 252
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 252
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 251
Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study 249
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial 249
Increased expression of interleukin-22 in patients with giant cell arteritis 249
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 249
Modulation of Cell Death and Promotion of Chondrogenic Differentiation by Fas/FasL in Human Dental Pulp Stem Cells (hDPSCs) 249
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 249
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 249
Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis 248
Thalidomide, deep venous thrombosis and vasculitis 248
Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study 248
Clinical Spectrum of Medium-Sized Vessel Vasculitis 248
Giant cell arteritis: Involvement of intracranial arteries 247
Totale 31.582
Salva come PNG Salva come JPEG
Categoria #
all - tutte 632.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 632.861
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.918 0 0 0 0 0 0 0 0 0 0 919 999
2021/202213.164 620 1.475 1.334 950 369 965 861 631 1.513 943 2.021 1.482
2022/202310.863 1.386 756 738 798 1.307 1.559 243 1.046 1.697 225 597 511
2023/20248.281 335 532 425 849 1.815 486 515 1.469 246 216 374 1.019
2024/202527.331 1.171 353 400 2.006 4.686 4.222 1.655 1.346 3.416 2.343 2.536 3.197
2025/202646.009 3.025 2.056 4.900 5.211 4.609 4.223 6.902 3.199 6.763 4.096 1.025 0
Totale 155.106